As of January 22, 2025, NRx Pharmaceuticals (NRXP) has a market cap of $42.087 million USD. According to our data, NRx Pharmaceuticals is ranked No.8255 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $42.09 M |
58.18%
|
Dec 31, 2024 | $26.61 M |
-52.17%
|
Dec 29, 2023 | $55.63 M |
-58.56%
|
Dec 30, 2022 | $0.13 B |
-76.78%
|
Dec 31, 2021 | $0.58 B |
-80.41%
|
Dec 31, 2020 | $2.95 B |
130.19%
|
Dec 31, 2019 | $1.28 B |
3.92%
|
Dec 31, 2018 | $1.23 B |
5.37%
|
Dec 29, 2017 | $1.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
BioCryst Pharmaceuticals
BCRX
|
$1.58 B |
0.000 M
|
USA
|
Catalyst Pharmaceuticals
CPRX
|
$2.73 B |
0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Omeros Corporation
OMER
|
$0.54 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
USA
|
Market Cap | = | NRXP Stock Price | * | NRXP Shares Outstanding |
= | $3.48 | * | 12.09 M | |
= | $42.09 M |